Comparable stake leader
VANGUARD CAPITAL MANAGEMENT LLC
SEC ownership of CME GROUP INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001156375.
Disclosed value leader
VANGUARD CAPITAL MANAGEMENT LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- CME on Nasdaq
- Parsed ownership sources
-
13D/G and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
VANGUARD CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001156375
- Issuer location
- Chicago, IL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CME GROUP INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
VANGUARD CAPITAL MANAGEME...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 7.4%
13D/G row: VANGUARD CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.4%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
VANGUARD CAPITAL MANAGEMENT LLC
7.4%
BlackRock, Inc.
8.4%
STATE STREET CORP
4.5%
MORGAN STANLEY
2.7%
GEODE CAPITAL MANAGEMENT, LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.4%
|
$7,987,654,803
27,044,709 shares
|
$0 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
8.4%
|
$6,749,965,373
30,566,342 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
Company
|
4.5%
|
$3,609,724,721
16,346,170 shares
|
— | 30 Jun 2026 |
| MORGAN STANLEY |
13F
Company
|
2.7%
|
$2,148,277,844
9,728,195 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.6%
|
$2,047,429,125
9,271,309 shares
|
— | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
2.5%
|
$2,024,464,325
9,167,524 shares
|
— | 30 Jun 2026 |
| Capital World Investors |
13F
Company
|
1.9%
|
$1,506,571,372
6,822,315 shares
|
— | 30 Jun 2026 |
| JPMORGAN CHASE & CO |
13F
Company
|
1.6%
|
$1,260,711,104
5,767,731 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$29,448,318.
Buys
$660,967
Insiders: 1
Sells
$30,109,285
Insiders: 10
Net
-$29,448,318
Shares: -102,199
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 2,345
Shares: 104,544
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 339 | 15,500 | $78,186 | $4,256,594 | -$4,178,408 |
| 3-6 | 1,470 | 40,753 | $437,101 | $12,200,402 | -$11,763,301 |
| 6-9 | 262 | 14,699 | $73,008 | $4,562,441 | -$4,489,433 |
| 9-12 | 274 | 33,592 | $72,672 | $9,089,848 | -$9,017,176 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 41 reporting-owner rows connected to CME GROUP INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
41
Largest Forms 3/4/5 holder
William R. Shepard
Net 12M change
-$29,345,614
Latest report
15 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| William R. Shepard | Director | $60,885,026 | +$660,967 | +1.1% | Filing P/S | 25 Jun 2026 |
| William W. Hobert | Director | $48,045,909 | Mixed | 01 May 2026 | ||
| Howard J. Siegel | Director | $34,027,524 | Mixed | 25 Jun 2026 | ||
| Patrick J. Mulchrone | Director | $18,055,436 | Mixed | 25 Jun 2026 | ||
| Larry G. Gerdes | Director | $17,643,970 | Mixed | 24 Apr 2025 | ||
| Julie Holzrichter | Sr MD Chief Operating Officer | $17,192,178 | Mixed | 15 Sep 2024 | ||
| Bryan T. Durkin | Director | $13,317,117 | -$1,300,530 | -8.9% | Mixed | 25 Jun 2026 |
| Kevin Kometer | Sr MD Chief Information Office | $12,795,625 | Mixed | 10 Feb 2022 | ||
| John W. Pietrowicz | Sr MD Chief Financial Officer | $11,182,381 | Mixed | 15 Sep 2022 | ||
| Terrence A. Duffy | Chairman and CEO, Director | $11,174,468 | -$21,303,221 | -66% | Mixed | 15 Sep 2026 |
| Hilda Harris Piell | Sr MD & Chief HR Officer | $8,438,860 | -$1,752,536 | -17% | Filing P/S | 18 May 2026 |
| Kathleen M. Cronin | Sr MD Gen Counsel & Corp Secr | $8,394,377 | Mixed | 15 Mar 2022 | ||
| Derek Sammann | Sr MD Gl Hd Commodities Mkts | $7,829,826 | -$1,984,798 | -20% | Mixed | 15 Sep 2026 |
| Martin J. Gepsman | Director | $7,647,194 | -$91,770 | -1.2% | Mixed | 25 Jun 2026 |
| Julie Winkler | Sr MD Chief Commercial Officer | $6,628,782 | Mixed | 15 Sep 2026 | ||
| Jack J. Tobin | MD Chief Accounting Officer | $6,517,835 | Mixed | 15 Sep 2026 | ||
| Robert J. Tierney Jr. | Director | $6,296,419 | Mixed | 25 Jun 2026 | ||
| Lynne Fitzpatrick | President and CFO | $5,436,682 | Mixed | 15 Sep 2026 | ||
| Timothy S. Bitsberger | Director | $5,285,791 | Mixed | 25 Jun 2026 | ||
| Elizabeth A. Cook | Director | $5,022,977 | -$460,055 | -8.4% | Mixed | 14 Sep 2026 |
Recent insider transactions for CME GROUP INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Julie Winkler | CME | Common Stock Class A | Tax liability | -1.12% | -359 | 31,561 | 16 Sep 2026 | Direct | ||
| Ken Vroman | CME | Common Stock Class A | Tax liability | -1.5% | -308 | 20,232 | 16 Sep 2026 | Direct | ||
| Jack J. Tobin | CME | Common Stock Class A | Tax liability | -0.2% | -51 | 25,762 | 16 Sep 2026 | Direct | ||
| Suzanne Sprague | CME | Common Stock Class A | Tax liability | -1.94% | -308 | 15,548 | 16 Sep 2026 | Direct | ||
| Derek Sammann | CME | Common Stock Class A | Tax liability | -3.42% | -359 | 10,134 | 16 Sep 2026 | Direct | ||
| Timothy Francis McCourt | CME | Common Stock Class A | Tax liability | -2.65% | -364 | 13,366 | 16 Sep 2026 | Direct | ||
| John Clifford Marchese | CME | Common Stock Class A | Tax liability | -1.21% | -44 | 3,598 | 16 Sep 2026 | Direct | ||
| Lynne Fitzpatrick | CME | Common Stock Class A | Tax liability | -1.33% | -359 | 26,661 | 16 Sep 2026 | Direct | ||
| Michael G. Dennis | CME | Common Stock Class A | Tax liability | -2.5% | -274 | 10,682 | 16 Sep 2026 | Direct | ||
| Sunil Cutinho | CME | Common Stock Class A | Tax liability | -1.41% | -359 | 25,037 | 16 Sep 2026 | Direct | ||
| Julie Winkler | CME | Common Stock Class A | Tax liability | -3.2% | -1,054 | 31,920 | 15 Sep 2026 | Direct | ||
| Julie Winkler | CME | Common Stock Class A | Award | 9.51% | 2,864 | 32,974 | 15 Sep 2026 | Direct | ||
| Ken Vroman | CME | Common Stock Class A | Tax liability | -4.21% | -903 | 20,540 | 15 Sep 2026 | Direct | ||
| Ken Vroman | CME | Common Stock Class A | Award | 13.8% | 2,592 | 21,443 | 15 Sep 2026 | Direct | ||
| Jack J. Tobin | CME | Common Stock Class A | Tax liability | -1.13% | -296 | 25,813 | 15 Sep 2026 | Direct | ||
| Jack J. Tobin | CME | Common Stock Class A | Award | 2.75% | 700 | 26,109 | 15 Sep 2026 | Direct | ||
| Suzanne Sprague | CME | Common Stock Class A | Tax liability | -5.05% | -844 | 15,856 | 15 Sep 2026 | Direct | ||
| Suzanne Sprague | CME | Common Stock Class A | Award | 20.7% | 2,864 | 16,700 | 15 Sep 2026 | Direct | ||
| Derek Sammann | CME | Common Stock Class A | Tax liability | -9.13% | -1,054 | 10,493 | 15 Sep 2026 | Direct | ||
| Derek Sammann | CME | Common Stock Class A | Award | 33% | 2,864 | 11,547 | 15 Sep 2026 | Direct | ||
| Timothy Francis McCourt | CME | Common Stock Class A | Tax liability | -6.6% | -970 | 13,730 | 15 Sep 2026 | Direct | ||
| Timothy Francis McCourt | CME | Common Stock Class A | Award | 21.4% | 2,592 | 14,700 | 15 Sep 2026 | Direct | ||
| John Clifford Marchese | CME | Common Stock Class A | Tax liability | -5.13% | -197 | 3,642 | 15 Sep 2026 | Direct | ||
| John Clifford Marchese | CME | Common Stock Class A | Award | 25.7% | 784 | 3,839 | 15 Sep 2026 | Direct | ||
| Lynne Fitzpatrick | CME | Common Stock Class A | Tax liability | -3.5% | -981 | 27,020 | 15 Sep 2026 | Direct | ||
| Lynne Fitzpatrick | CME | Common Stock Class A | Award | 17.1% | 4,088 | 28,001 | 15 Sep 2026 | Direct | ||
| Terrence A. Duffy | CME | Common Stock Class A | Award | 53.7% | 21,812 | 62,442 | 15 Sep 2026 | Direct | ||
| Michael G. Dennis | CME | Common Stock Class A | Tax liability | -2.44% | -274 | 10,956 | 15 Sep 2026 | Direct | ||
| Michael G. Dennis | CME | Common Stock Class A | Award | 30% | 2,592 | 11,230 | 15 Sep 2026 | Direct | ||
| Sunil Cutinho | CME | Common Stock Class A | Tax liability | -3.98% | -1,054 | 25,396 | 15 Sep 2026 | Direct | ||
| Sunil Cutinho | CME | Common Stock Class A | Award | 12.1% | 2,864 | 26,450 | 15 Sep 2026 | Direct | ||
| Elizabeth A. Cook | CME | Common Stock Class A | Sale | -2.72% | $140,055 | $280.11 | -500 | 17,916 | 14 Sep 2026 | by Trust |
| Terrence A. Duffy | CME | Common Stock Class A | Sale | -27% | $4,116,539 | $274.44 | -15,000 | 40,630 | 10 Sep 2026 | Direct |
| Robert J. Tierney Jr. | CME | Common Stock Class A | Award | 4.71% | 645 | 14,345 | 25 Jun 2026 | Direct | ||
| Martin J. Gepsman | CME | Common Stock Class A | Award | 2.58% | 645 | 25,644 | 25 Jun 2026 | Direct | ||
| William R. Shepard | CME | Common Stock Class A | Purchase | 0.12% | $74,885 | $230.57 | 325 | 260,442 | 25 Jun 2026 | by Trust |
| William R. Shepard | CME | Common Stock Class A | Purchase | 0.4% | $3,301 | $230.57 | 14.32 | 3,621 | 25 Jun 2026 | Direct |
| William R. Shepard | CME | Common Stock Class A | Award | 42% | 1,067 | 3,606 | 25 Jun 2026 | Direct | ||
| Rahael Seifu | CME | Common Stock Class A | Award | 15.8% | 645 | 4,739 | 25 Jun 2026 | Direct | ||
| Dennis A. Suskind | CME | Common Stock Class A | Award | 23.9% | 645 | 3,344 | 25 Jun 2026 | Direct | ||
| Howard J. Siegel | CME | Common Stock Class A | Award | 2.23% | 1,067 | 48,858 | 25 Jun 2026 | Direct | ||
| Patrick J. Mulchrone | CME | Common Stock Class A | Award | 2.26% | 645 | 29,130 | 25 Jun 2026 | Direct | ||
| Patrick W. Maloney | CME | Common Stock Class A | Award | 15.7% | 645 | 4,743 | 25 Jun 2026 | Direct | ||
| Deborah J. Lucas | CME | Common Stock Class A | Award | 16.6% | 645 | 4,533 | 25 Jun 2026 | Direct | ||
| Phyllis M. Lockett | CME | Common Stock Class A | Award | 17.7% | 645 | 4,285 | 25 Jun 2026 | Direct | ||
| Daniel G. Kaye | CME | Common Stock Class A | Award | 15.4% | 645 | 4,845 | 25 Jun 2026 | Direct | ||
| William W. Hobert | CME | Common Stock Class A | Award | 1% | 1,067 | 108,006 | 25 Jun 2026 | Direct | ||
| Harold E. Ford Jr. | CME | Common Stock Class A | Award | 97.8% | 1,067 | 2,158 | 25 Jun 2026 | Direct | ||
| Bryan T. Durkin | CME | Common Stock Class A | Award | 1.5% | 645 | 43,652 | 25 Jun 2026 | Direct | ||
| Elizabeth A. Cook | CME | Common Stock Class A | Award | 3.63% | 645 | 18,416 | 25 Jun 2026 | by Trust |
* marks a reported price that did not pass the local price check.